Our results showed that plasma Tgfβ1 levels were lower in breast cancer patients than in ovarian cancer and CRC patients, although no significant difference was observed in plasma Tgfβ1 levels between patients with ovarian cancer and CRC (Fig. 7C, Table S4). Here, TGFB1 is linked to breast cancer.